← All companies
Stagepre-seed
Founded2023
Employees5
LocationNashville, TN
About
Our AI-Enabled Clinical Efficacy Platform lowers specialty pharmacy spend by certifying and recertifying only therapies that work. Using our platform, plans combine their own clinical guidelines with longitudinal patient monitoring, to evaluate whether patients are achieving a therapy’s intended clinical endpoint, providing clear insight into what matters most: is the medication working for each member?
Product
- Value proposition
- AI-enabled Clinical Efficacy Platform that certifies and recertifies therapies that work, lowering specialty pharmacy spend and improving clinical outcomes while streamlining prior authorizations.
- Target customers
- Health plans, payers, and health systems that manage prior authorizations for specialty medications
Founders
- J. Mark McConnell — Co-Founder & CEO
- Leigh Ann Ruggles — Co-Founder & Chief Growth Officer
- Jim Notaro, R.Ph., Ph.D. — Co-Founder, Chief Pharmacy & Product Officer
- Mark Nathan — Co-Founder & Advisor
Products
Clinical Efficacy PlatformPrior Authorization automation toolsData-driven guidelines-to-algorithms converterProvider outreach automation
Key features
AI-enabled evaluation of longitudinal patient data against medication outcomesmachine-readable clinical guidelinescontinual assessment to eliminate ineffective therapiesgold-carding of members on effective therapiesautomation of provider outreachcost prediction and contracting supportimproved member experience and reduced administrative costs
Technologies
AI/MLdata integrationclinical guidelines automationlongitudinal patient data analysis
Target conditions
GLP-1sspecialty medicationsprior authorization processesdrug efficacyclinical endpoints
Care settings
plans/health insurerspharmacy benefit managershealth planspayer organizations
Certifications
HIPA Acknowledgement not explicitFDA status not stated
Traction metrics
“lowering speciality pharmacy spend”reducing costsimproving clinical outcomesfaster prior authorizations
Investors
Flare Capital PartnersSWL Healthcare VenturesTwo Sons Investmentsseveral angel investors
News
- Ethicos Health Launches to Align Specialty Drug Coverage with Clinical Effectiveness - Ethicos Health · 2026-01-07T18:27:17.000Z
- Ethicos Health Launches to Align Specialty Drug Coverage with Clinical Effectiveness · 2026-01-07T18:06:00.000Z
- Transparent PBM Araya Announces Partnership with Ethicos Health - Ethicos Health · 2026-02-10T16:40:10.000Z
- Araya Launches "Max," a next generation Prior Authorization Solution Powered by Ethicos Health's Clinical Efficacy Platform · 2026-02-10T16:33:00.000Z
- Cut and Run - United Bailing on Prior Auth. - Ethicos Health · 2026-05-07T18:47:51.000Z
- Araya Announces Strategic Network Expansion with Mark Cuban's Cost Plus Drugs - Araya Pharmacy Benefit Management · 2026-02-09T19:11:44.000Z


